Palatinose for enhancing dietary supplement and pharmaceutical delivery

Abstract

The present invention is directed to a dietary supplement comprising palatinose or a derivative thereof. The dietary supplement may be a nutritional product, a sports performance product, a weight loss product or a meal replacement product. The present invention is also directed to a method of increasing the absorption of a compound into the bloodstream, cells and tissue comprising administering palatinose, or a derivative thereof, in combination with the compound. The present invention also relates to a diluent for parenteral compounds. The diluent comprises palatinose or a derivative thereof. Another aspect of the present invention is directed to a method of decreasing the recovery time to pre-performance levels of total adenosine triphosphate (ATP) levels in a mammal comprising administering palatinose, or a derivative thereof, to the mammal. The present invention is further directed to a method of supplying a compound to a diabetic patient, burn victim patient or trauma victim patient. The method comprises administering palatinose, or a derivative thereof, in combination with the compound.

What is claimed is: 
     
         1 . A dietary supplement comprising isomaltulose and carnitine or a salt, ester or chelate thereof, wherein the concentration of isomaltulose is between about 10% and about 85%, and wherein the dietary supplement is in a form selected from the group consisting of a tablet, capsule, powder or drink. 
     
     
         2 . The dietary supplement of  claim 1 , wherein the dietary supplement is a nutritional product, a sports performance product, a weight loss product, or a meal replacement product. 
     
     
         3 . The dietary supplement of  claim 1 , wherein the concentration of carnitine is between about 10% and about 50%. 
     
     
         4 . The dietary supplement of  claim 1 , further comprising one or more compounds selected from the group consisting of a sugar, a stimulant, an amino acid, and a mineral. 
     
     
         5 . The dietary supplement of  claim 1 , further comprising one or more compounds selected from the group consisting of trehalose; amylose; glucose; a methylxanthine; arginine or a salt, ester or chelate thereof; amylopectin; L-carnosine; calcium carbonate; sodium bicarbonate; glucuronolactone; sulbutiamine or fursultiamine; disodium adenosine phosphate; adenosine triphosphate; orotic acid; vinpocetine or rhodiola rosea; cellulose; and starch. 
     
     
         6 . The dietary supplement of  claim 1 , further comprising one or more compounds selected from the group consisting of citrulline or a salt, ester or chelate thereof; taurine or a salt, ester or chelate thereof; arginine or a salt, ester or chelate thereof; carnosine or a salt, ester or chelate thereof; pyruvate or a salt, ester or chelate thereof; tyrosine or a salt, ester or chelate thereof; tyramine or a salt, ester or chelate thereof; histidine or a salt, ester or chelate thereof; alanine or a salt, ester or chelate thereof; phenylalanine or a salt, ester or chelate thereof; 4-hydroxy-isoleucine; ornithine or a salt, ester or chelate thereof; glutamine; branched chain amino acids or a salt, ester or chelate thereof; an amino acid chelate; 5-hydroxy-tryptophan; and choline. 
     
     
         7 . The dietary supplement of  claim 1 , further comprising Coenzyme Q-10 and one or more of creatine, a creatine salt, a creatine ester and a creatine chelate. 
     
     
         8 . The dietary supplement of  claim 1 , further comprising one or more of creatine, a creatine salt, a creatine ester and a creatine chelate. 
     
     
         9 . The dietary supplement of  claim 1 , further comprising coenzyme Q10. 
     
     
         10 . The dietary supplement of  claim 1 , further comprising one or more stimulants. 
     
     
         11 . The dietary supplement of  claim 10 , wherein the one or more stimulants are selected from the group consisting of caffeine; octopamine; norsynephrine; synephrine; ephedrine; hordenine; theobromine; sulbutiamine; fursultiamine; octotiamine; and adrafanil. 
     
     
         12 . The dietary supplement of  claim 1 , further comprising carbon dioxide. 
     
     
         13 . A method of increasing the absorption of carnitine or a salt, ester or chelate thereof into the bloodstream of a mammal, wherein the method comprises administering to the mammal a composition comprising isomaltulose and carnitine or a salt, ester or chelate thereof. 
     
     
         14 . The method of  claim 13 , wherein the composition is selected from the group consisting of a dietary supplement, a nutrient or a pharmaceutical. 
     
     
         15 . The method of  claim 13 , wherein the composition is in a form selected from the group consisting of a tablet, capsule, powder or drink. 
     
     
         16 . The method of  claim 13 , wherein the concentration of isomaltulose in the composition is between about 10% and about 85%. 
     
     
         17 . The method of  claim 13 , wherein the concentration of isomaltulose in the composition is between about 10% and about 50%. 
     
     
         18 . The method of  claim 13 , wherein the composition comprises between about 0.5 grams and about 200 grams of isomaltulose. 
     
     
         19 . The method of  claim 13 , wherein the composition further comprises one or more of creatine, a creatine salt, a creatine ester and a creatine chelate. 
     
     
         20 . The method of  claim 13 , wherein the composition further comprises one or more compounds selected from the group consisting of a sugar; a stimulant; creatine or a salt, ester or chelate thereof; coenzyme Q-10; 7-keto-DHEA; a mineral; an undigestible bulk-forming starch; adenosine triphosphate; carbon dioxide; trehalose; amylose; glucose; a methylxanthine; amylopectin; calcium carbonate; sodium bicarbonate; glucuronolactone; sulbutiamine; fursultiamine; orotic acid; vinpocetine; rhodiola rosea; and cellulose.